focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 23.25
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.50 (2.174%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 23.25
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director dealings: Angle CEO, finance chief join capital raise

Tue, 19th Jul 2022 16:35

(Sharecast News) - Liquid biopsy specialist Angle had two entries on the list of director buys on Tuesday, after its chief executive and chief financial officers invested in shares.

The AIM-traded firm said CEO Andrew Newland bought 125,000 shares for 80p each, spending a total of £100,000.

At the same time, its CFO Ian Griffiths spent £30,000 on 37,500 shares, also at 80p apiece.

Both transactions took place off-market, as part of the company's capital raise of £20.13m through a placing, retail offer and management subscription, announced on Friday.

Reporting by Josh White at Sharecast.com.

Top Director Buys

Alphawave Ip Group (AWE)

Director name: Sutardja,Sehat

Amount purchased: 538,867 @ 121.84p

Value: £656,555.55

Angle (AGL)

Director name: Newland,Andrew D

Amount purchased: 125,000 @ 80.00p

Value: £100,000.00

Fevertree Drinks (FEVR)

Director name: Havelock,Kevin

Amount purchased: 10,000 @ 887.70p

Value: £88,770.00

Fevertree Drinks (FEVR)

Director name: Havelock,Kevin

Amount purchased: 10,000 @ 871.54p

Value: £87,154.00

Fevertree Drinks (FEVR)

Director name: Havelock,Kevin

Amount purchased: 4,000 @ 877.10p

Value: £35,084.00

Angle (AGL)

Director name: Griffiths,Ian F

Amount purchased: 37,500 @ 80.00p

Value: £30,000.00

Fevertree Drinks (FEVR)

Director name: Havelock,Kevin

Amount purchased: 2,816 @ 887.54p

Value: £24,993.13

Schroder British Opportunities Trust (SBO)

Director name: Bartlett,Diana Dyer

Amount purchased: 26,345 @ 75.50p

Value: £19,890.47

Fevertree Drinks (FEVR)

Director name: Havelock,Kevin

Amount purchased: 2,000 @ 960.00p

Value: £19,200.00

Fevertree Drinks (FEVR)

Director name: Havelock,Kevin

Amount purchased: 2,000 @ 956.58p

Value: £19,131.60

More Acquisitions (TMOR)

Director name: McIllree ,Roderick

Amount purchased: 2,000,000 @ 0.95p

Value: £18,900.00

Schroder British Opportunities Trust (SBO)

Director name: England,Neil

Amount purchased: 25,000 @ 75.15p

Value: £18,787.50

Audioboom Group (BOOM)

Director name: Last,Stuart

Amount purchased: 1,218 @ 820.00p

Value: £9,987.60

Audioboom Group (BOOM)

Director name: Last,Stuart

Amount purchased: 1,410 @ 708.25p

Value: £9,986.32

Audioboom Group (BOOM)

Director name: Tobin,Michael

Amount purchased: 1,117 @ 850.00p

Value: £9,494.50

Genflow Biosciences (GENF)

Director name: Leire,Eric

Amount purchased: 308,999 @ 3.03p

Value: £9,362.67

Velocys Plc (VLS)

Director name: Sanderson,Philip

Amount purchased: 200,000 @ 4.30p

Value: £8,600.00

Time Finance (TIME)

Director name: Roberts ,James

Amount purchased: 26,972 @ 18.50p

Value: £4,989.82

Schroder British Opportunities Trust (SBO)

Director name: Jenkinson,Tim

Amount purchased: 6,609 @ 75.15p

Value: £4,966.53

Schroder British Opportunities Trust (SBO)

Director name: OBE,Christopher Keljik,

Amount purchased: 6,577 @ 75.50p

Value: £4,965.50

Time Finance (TIME)

Director name: Telling,Julian

Amount purchased: 26,000 @ 18.85p

Value: £4,901.00

Coca-cola Hbc Ag (cdi) (CCH)

Director name: Bogdanovic,Zoran

Amount purchased: 218 @ 1,956.75p

Value: £4,265.71

Time Finance (TIME)

Director name: Raynes ,Tanya

Amount purchased: 21,156 @ 18.85p

Value: £3,987.91

Bae Systems (BA.)

Director name: Woodburn,Charles

Amount purchased: 19 @ 804.96p

Value: £152.94

Bae Systems (BA.)

Director name: Greve,Brad

Amount purchased: 19 @ 804.96p

Value: £152.94

(HWG)

Director name: Birch,Chris

Amount purchased: 107 @ 140.00p

Value: £149.80

(HWG)

Director name: Patmore,Katerina

Amount purchased: 107 @ 140.00p

Value: £149.80

(HWG)

Director name: Shillaw,Lynda

Amount purchased: 107 @ 140.00p

Value: £149.80

More News
4 Jan 2024 12:09

LONDON MARKET MIDDAY: Retailers Next and JD Sports bookend FTSE 100

(Alliance News) - Stock prices in London were slightly higher at midday on Thursday, with the FTSE 100 looking set to snap the two-day losing streak it suffered at the start of the year.

Read more
4 Jan 2024 10:43

AIM WINNERS & LOSERS: Angle soars on clinical tests; Likewise sales up

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
4 Jan 2024 08:58

LONDON MARKET OPEN: Next leads buoyant FTSE 100 amid services PMIs

(Alliance News) - Stock prices in London opened up on Thursday, amid a slew of services PMI data, including for the UK, while reacting to the latest data from China.

Read more
4 Jan 2024 07:58

Angle receives 'breakthrough results' from DNA molecular analysis

(Sharecast News) - Liquid biopsy company Angle received "breakthrough results" from DNA molecular analysis of cancer patient blood samples on Thursday, sending its shares skywards as a result.

Read more
2 Jan 2024 09:04

Angle locks in $250,000 contract with Eisai

(Sharecast News) - Liquid biopsy company Angle has locked in a $250,000 contract with global pharmaceutical company Eisai to deliver circulating tumour cell analysis in a pilot study.

Read more
2 Jan 2024 08:51

IN BRIEF: Angle teams with Japan's Eisai in breast cancer drug trial

Angle PLC - Surrey, England-based medical diagnostics - Signs contract with Eisai Inc, part of Tokyo-based pharmaceutical firm Eisai Co Ltd. Under the agreement, the two will engage in a pilot study worth USD250,000 to Angle. Angle will provide circulating-tumour-cells analysis using its Portrait HER2 assay to assess the response of breast cancer patients to Eisai's BB-1701 antibody-drug conjugate. BB-1701 targets HER2, a protein that speeds up the growth of breast cancer cells. Success in the phase two pilot study will offer the possibility for multiple follow-up studies.

Read more
11 Dec 2023 20:44

TRADING UPDATES: Ondine Biomedical raises GBP2.9 million via placing

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
5 Dec 2023 11:50

IN BRIEF: Angle launches diagnostic kit at cancer symposium

Angle PLC - Surrey, England-based medical diagnostics company - Launches its Portrait Plus CTC staining kit at the San Antonio Breast Cancer Symposium, following "extensive" development, optimisation and validation of the kit. Explains that the kit is read-to-use, and designed for the dentification, characterisation and enumeration of epithelial and mesenchymal cancer cells. This includes those undergoing epithelial-to-mesenchymal transition.

Read more
9 Nov 2023 14:29

Angle says build up of revenue slower than hoped; launches test

(Alliance News) - Angle PLC on Thursday said it expects revenue in 2023 to more than double from 2022 as it announced the launch of a new test aimed to support cancer therapy studies.

Read more
25 Oct 2023 17:28

TRADING UPDATES: Franchise Brands trading in line; Tribe secures loan

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
3 Oct 2023 13:02

Angle hails study which shows Parsortix outperforming lab standard

(Alliance News) - Angle PLC on Tuesday touted the publication of a study by researchers at the University of Tubingen in Germany, which showed that its Parsortix system outperformed the current laboratory standard for disseminated tumour cell harvest.

Read more
14 Sep 2023 09:22

LONDON BROKER RATINGS: JPMorgan ups Rio Tinto; Redburn likes Carnival

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
7 Sep 2023 14:41

EARNINGS UPDATES: Sylvania beats production goal, Angle revenue surges

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on xxxday and not separately reported by Alliance News:

Read more
7 Sep 2023 11:20

AIM WINNERS & LOSERS: CVS plunges on CMA vet probe; Angle ascends

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
4 Sep 2023 14:21

Angle launches tumour cell assay to "unlock" customised cancer care

(Alliance News) - Angle PLC on Monday announced the launch of its new Portrait Flex circulating tumour cell assay, which it said will provide valuable trial data and help advance "personalised cancer care."

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.